Woman with advanced Alzheimer's regained speech and memories after taking magic mushrooms

A woman with advanced Alzheimer's reportedly showed significant brain function improvements after taking psilocybin mushrooms ...

Common myths about Alzheimer’s disease that still mislead millions of people: From ‘it’s just normal ageing’ to ‘only older people get it,’ here’s what experts ...

Alzheimer's disease is the most common cause of dementia, accounting for roughly 60 to 70 percent of all cases worldwide.

Her Mother Has Alzheimer’s. Can They Afford a Memory Care Facility at $95,000 a Year?

Karen’s mother has Alzheimer’s disease, and the family has reached the point where living independently is no longer an ...

ETH Zurich scientists developed a new drug to slow Alzheimer’s development

Alzheimer’s disease slowly strips brain cells of the energy they need to survive. However, one damaged enzyme may be doing ...
TCTMD

CVD Risk Factors, Including Hypotension, Linked to Alzheimer’s Disease

Race and ethnicity modified the associations, with the hypotension connection considered to be hypothesis-generating.

Elixiron Immunotherapeutics Reports Positive Phase 2 Interim Results for Enrupatinib: Evidence of Neuroinflammation Reduction and Early Cognitive Benefit in Alzheimer's Disease

Elixiron Immunotherapeutics (TPEx: 7871), a clinical-stage biopharmaceutical company pioneering precision immunotherapy for neurodegenerative and autoimmune diseases, today announced positive interim ...

West Texas Alzheimer’s events aim to support caregivers, raise awareness

The Alzheimer’s Association is inviting residents to take part in two upcoming events focused on supporting caregivers and ...

Baltimore City files lawsuit against Agora Companies over deceptive business practices

Baltimore City is suing a global internet marketing and supplements company, alleging that it targets people, especially the ...